84 related articles for article (PubMed ID: 22325970)
21. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer.
Frigola J; Solé X; Paz MF; Moreno V; Esteller M; Capellà G; Peinado MA
Hum Mol Genet; 2005 Jan; 14(2):319-26. PubMed ID: 15574462
[TBL] [Abstract][Full Text] [Related]
22. Long interspersed nucleotide element-1 hypomethylation in folate-deficient mouse embryonic stem cells.
Chang S; Wang L; Guan Y; Shangguan S; Du Q; Wang Y; Zhang T; Zhang Y
J Cell Biochem; 2013 Jul; 114(7):1549-58. PubMed ID: 23297156
[TBL] [Abstract][Full Text] [Related]
23. Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
Chen G; Wang Y; Huang H; Lin F; Wu D; Sun A; Chang H; Feng Y
Eur J Haematol; 2009 Mar; 82(3):176-83. PubMed ID: 19077051
[TBL] [Abstract][Full Text] [Related]
24. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
25. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
26. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
27. No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy.
van der Kooi EL; de Greef JC; Wohlgemuth M; Frants RR; van Asseldonk RJ; Blom HJ; van Engelen BG; van der Maarel SM; Padberg GW
Neuromuscul Disord; 2006 Nov; 16(11):766-9. PubMed ID: 17005397
[TBL] [Abstract][Full Text] [Related]
28. Relevance of folate metabolism in the pathogenesis of colorectal cancer.
Ryan BM; Weir DG
J Lab Clin Med; 2001 Sep; 138(3):164-76. PubMed ID: 11528369
[TBL] [Abstract][Full Text] [Related]
29. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
Pascale RM; Simile MM; Feo F
Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
[TBL] [Abstract][Full Text] [Related]
30. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
31. Folate and DNA methylation.
Ly A; Hoyt L; Crowell J; Kim YI
Antioxid Redox Signal; 2012 Jul; 17(2):302-26. PubMed ID: 22332737
[TBL] [Abstract][Full Text] [Related]
32. Modulation of dietary folate with age confers selective hepatocellular epigenetic imprints through DNA methylation.
Najar RA; Wani NA; Bhat JA; Dar NJ; Rahat B; Gupta AP; Kaur J; Kaur J; Hamid A
J Nutr Biochem; 2018 Mar; 53():121-132. PubMed ID: 29220669
[TBL] [Abstract][Full Text] [Related]
33. Reversal of DNA hypomethylation by folic acid supplements: possible role in colorectal cancer prevention.
Mathers JC
Gut; 2005 May; 54(5):579-81. PubMed ID: 15831897
[No Abstract] [Full Text] [Related]
34. Folate: effects on carcinogenesis and the potential for cancer chemoprevention.
Mason JB; Levesque T
Oncology (Williston Park); 1996 Nov; 10(11):1727-36, 1742-3; discussion 1743-4. PubMed ID: 8953590
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation in brain development and gliomagenesis.
Costello JF
Front Biosci; 2003 Jan; 8():s175-84. PubMed ID: 12456310
[TBL] [Abstract][Full Text] [Related]
36. ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients.
Debien E; Hervouet E; Gautier F; Juin P; Vallette FM; Cartron PF
Clin Epigenetics; 2011 Aug; 2(2):369-381. PubMed ID: 21949549
[TBL] [Abstract][Full Text] [Related]
37. Is it time to start folate supplementation in men? The effect of paternal folate status on embryonic growth.
Cheng PJ; Pastuszak AW; Hotaling JM
Fertil Steril; 2019 Feb; 111(2):251-252. PubMed ID: 30598167
[No Abstract] [Full Text] [Related]
38. Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from
Greger H
Phytochem Rev; 2022; 21(3):725-764. PubMed ID: 34104125
[TBL] [Abstract][Full Text] [Related]
39. The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
Kaneda A; Seike T; Danjo T; Nakajima T; Otsubo N; Yamaguchi D; Tsuji Y; Hamaguchi K; Yasunaga M; Nishiya Y; Suzuki M; Saito JI; Yatsunami R; Nakamura S; Sekido Y; Mori K
Am J Cancer Res; 2020; 10(12):4399-4415. PubMed ID: 33415007
[TBL] [Abstract][Full Text] [Related]
40. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
